Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Multicenter Double-bind Placebo-controlled Randomized Parallel-group Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other Acute Respiratory Viral Infections in Children During the Peaks of Seasonal Morbidity

NCT03301155 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT03301155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03301155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Multicenter Double-bind Placebo-controlled Randomized Parallel-group Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other Acute Respiratory Viral Infections in Children During the Peaks of Seasonal Morbidity
Lead sponsor
Materia Medica Holding
Phase
Phase 4
Overall status
Completed
Start date
October 3, 2017
Completion date
May 20, 2019
Enrollment
1,036 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

preventive medicine